Liquid biopsies in patients with multiple myeloma precursor conditions

Updated: Sep 28, 2018

Mark W. Bustoros, MD, a postdoctoral fellow at Dana-Farber Cancer Institute, Harvard Medical School, discusses ongoing research exploring the use of liquid biopsies in patients with smoldering multiple myeloma in this Targeted Oncology +watch video

Mark Bustoros, MD

.

Recent Posts

See All

Honoring a decade of Standing Up To Cancer

On September 7, Stand Up To Cancer’s (SU2C) telecast shared inspiring stories of hope, perseverance, and groundbreaking cancer research to a worldwide audience. +read more

DFCI Logo Lens Stacked PNG_edited.png
CPOP_R02.png

© 2018 Dana-Farber Cancer Institute |  Terms of Use  |   Privacy Policy